In mouse colorectal cancer models, NAC demonstrated a synergistic effect with PD-1 blockers against tumour progression by promoting CD8+ T cell glucose metabolism and inducing TCF1+PD1+CD8+ T cell differentiation. The gene discussed is CD8A; the disease is colorectal cancer.